StockNews.com initiated coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a report released on Friday morning. The firm issued a hold rating on the biopharmaceutical company’s stock.
Sorrento Therapeutics Stock Performance
Shares of SRNE opened at $0.01 on Friday. Sorrento Therapeutics has a fifty-two week low of $0.00 and a fifty-two week high of $0.35. The firm has a 50 day moving average price of $0.01 and a 200-day moving average price of $0.02.
Sorrento Therapeutics Company Profile
Featured Articles
- Five stocks we like better than Sorrento Therapeutics
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- MarketBeat Week in Review – 7/22 – 7/26
- What is Forex and How Does it Work?
- 3M Surprises and Rebound Accelerates: It Isn’t Too Late To Get In
- What is a Bond Market Holiday? How to Invest and Trade
- Skechers Stock Shows Strength Among Consumer Discretionary Sector
Receive News & Ratings for Sorrento Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sorrento Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.